文献速递肿瘤 PET/CT神经核医学

68Ga-DOTATATE PET/MRI在神经内分泌肿瘤中的应用:图解综述

68Ga-DOTATATE PET/MRI for Neuroendocrine Tumors: A Pictorial Review.
PubMed 文献 · Clin Nucl Med · 2020-01-01

本文为图解综述,旨在展示68Ga-DOTATATE PET/MRI在神经内分泌肿瘤评估中的互补优势与不足。综述指出,PET/MRI因MRI软组织对比度优于CT,尤其适用于怀疑或需排除肝转移的神经内分泌肿瘤检测与表征。

要点

  • 68Ga-DOTATATE PET是神经内分泌肿瘤的新型成像技术。
  • PET/MRI因MRI软组织对比度优于CT,尤其适合神经内分泌肿瘤评估。
  • PET/MRI在怀疑或需排除肝转移时有助于改善检测与表征。

核心结论

  • 本图解综述旨在展示68Ga-DOTATATE PET/MRI在神经内分泌肿瘤评估中的互补优势与不足。

研究设计与样本

  • 本文为图解综述,未报告系统检索范围。

主要发现

  • 神经内分泌肿瘤具有不同程度的神经内分泌分化与表型及遗传特征。
  • 68Ga-DOTATATE PET是神经内分泌肿瘤的新型成像技术。
  • PET/MRI因MRI软组织对比度优于CT,尤其适合神经内分泌肿瘤评估,在怀疑或需排除肝转移时有助于改善检测与表征。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Neuroendocrine tumors (NETs) constitute a variety of neoplastic entities and exhibit variable degrees of neuroendocrine differentiation and phenotypes, as well as genetic profiles. Ga-DOTATATE PET is a novel imaging technique for NET. Although PET/CT is commonly utilized for oncologic imaging, PET/MRI is particularly suited for NETs, as MRI provides greater soft tissue contrast than CT, allowing for improved detection and characterization of NETs, particularly when liver metastasis is suspected or needs to be ruled out. The current pictorial review aims to illustrate the complementary advantages, as well as pitfalls of Ga-DOTATATE PET/MRI in the evaluation of NETs.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Nguyen NC, Moon CH, Muthukrishnan A, et al. 68Ga-DOTATATE PET/MRI for Neuroendocrine Tumors: A Pictorial Review. Clin Nucl Med. 2020. PMID: 32520493. doi:10.1097/RLU.0000000000003085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。